1. Australia Government, Department of Health. Pharmaceutical Benefits Scheme. Available at http://www.pbs.gov.au/pbs/home Accessed: October 2014 2. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Currents 2011;11:56-63 3. ILAE/IBE/WHO, Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. Available at; http://www.ilae.org/Visitors/Documents/ILAEAnnual-Report2010Final_000.pdf Accessed: October 2014 4. Epilepsy Action Australia. Facts and statistics about Epilepsy. Available at: http://www.epilepsy.org.au/resources/for-media/facts-statistics-about-epilepsy Accessed: October 2014 5. French JA. Refractory Epilepsy; Clinical Overview. Epilepsia 2007: 48 (Suppl1) 3-7 6. French JA et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012:79(6):589-596 7. French JA et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305. Epilepsia 2013:54(1):117-125 8. Krauss GM et al. Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures. Neurology 2012:78(18):1408-1415 9. Krauss GL et al. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalised seizures: Results from Phase III extension study 307. Epilepsia 2014;55:1058-1068 10. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe. http://www.ibe-epilepsy.org/downloads/EURO%20Report%20160510.pdf Accessed: October 2014 11. Pugliatti M et al. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia 2007:48(12):2224-2233
Fecha de preparación: noviembre de 2014
Código de trabajo: Perampanel-UK2177aCONTACTO: Consultas de los medios de comunicación: Eisai Europe Ltd:Cressida Robson / Ben Speller, +44(0)7908-314-155 / +44(0)7908-409416,Cressida_Robson@eisai.net / Ben_Speller@eisai.net. Tonic LifeCommunications: Ainsley Cooper / Nicola Lilley, +44-(0)20-7798-9907 /+44-(0)207-798-9905, Ainsley.Cooper@toniclc.com /Nicola.Lilley@toniclc.com.
Hemos bloqueado los comentarios de este contenido. Sólo se mostrarán los mensajes moderados hasta ahora, pero no se podrán redactar nuevos comentarios.
Consulta los casos en los que lainformacion.com restringirá la posibilidad de dejar comentarios